PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Glycopyrronium bromide
Presentation Product Chemical substance Chapter Items dispensed
Seebri Breezhaler 44microgram inhalation pdr caps with dev
0301020S0BBAAAA
Seebri Glycopyrronium bromide Respiratory System 54,016
Glycopyrronium bromide 200micrograms/1ml inj ampoules
1501030G0AAAAAA
Glycopyrronium brom (Pre-med) Glycopyrronium bromide Anaesthesia 24,296
Glycopyrronium bromide 1mg/5ml oral solution sugar free
0102000L0AABNBN
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 12,306
Glycopyrronium bromide 55microg inhalation pdr caps with dev
0301020S0AAAAAA
Glycopyrronium bromide (Inhalation) Glycopyrronium bromide Respiratory System 7,530
Glycopyrronium bromide 600micrograms/3ml inj ampoules
1501030G0AAABAB
Glycopyrronium brom (Pre-med) Glycopyrronium bromide Anaesthesia 6,055
Glycopyrronium bromide 400micrograms/ml soln sugar free
0102000L0AABQBQ
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 4,239
Sialanar 320micrograms/ml oral solution
0102000L0BCAABQ
Sialanar Glycopyrronium bromide Gastro-Intestinal System 3,270
Glycopyrronium bromide 1mg tablets
0102000L0AAACAC
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 2,920
Glycopyrronium bromide 2mg tablets
0102000L0AAAAAA
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 1,644
Assicco 1mg tablets
0102000L0BDAAAC
Assicco Glycopyrronium bromide Gastro-Intestinal System 856
Assicco 2mg tablets
0102000L0BDABAA
Assicco Glycopyrronium bromide Gastro-Intestinal System 445
Glycopyrronium bromide 1mg/5ml oral liquid
0102000L0AAADAD
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 440
Glycopyrronium bromide 5mg/5ml oral suspension
0102000L0AABGBG
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 331
Glycopyrronium bromide 5mg/5ml oral solution
0102000L0AABFBF
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 295
Glycopyrronium bromide 200micrograms/5ml oral solution
0102000L0AABDBD
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 150
Glycopyrronium bromide 200micrograms/5ml oral suspension
0102000L0AABEBE
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 77
Glycopyrronium bromide 500micrograms/5ml oral solution
0102000L0AABHBH
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 69
Glycopyrronium bromide 2% in Cetomacrogol cream (Formula A)
1312000G0AABGBG
Glycopyrronium (Topical) Glycopyrronium bromide Skin 54
Glycopyrronium bromide 0.05% topical solution
1312000G0AABCBC
Glycopyrronium (Topical) Glycopyrronium bromide Skin 49
Glycopyrronium bromide 2mg/5ml oral liquid
0102000L0AAAIAI
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 46
Glycopyrronium bromide 500micrograms/5ml oral suspension
0102000L0AABIBI
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 45
Glycopyrronium bromide 2.5mg/5ml oral suspension
0102000L0AABCBC
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 44
Glycopyrronium bromide 3mg/5ml oral liquid
0102000L0AAAHAH
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 7
Glycopyrronium bromide 1mg capsules
0102000L0AABPBP
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 6
Glycopyrronium bromide 2.5mg/5ml oral solution
0102000L0AABBBB
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System 5

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.